MoneyWorks4Me

Vivo Bio Tech informs about statement of investor complaints

21 Oct 2017 Evaluate

Vivo Bio Tech has informed about Statement of Investor Grievance Redressal Report for the quarter ended 30th September, 2017 in compliance with Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..